FDA Inspection
Lupin Ltd.Lupin Ltd. – FDA Inspection, Jul 28, 2017
Record Details
This FDA Inspection record concerns Lupin Ltd., with an inspection on July 28, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · d6bfb207-9258-4f5d-919d-f81ef16c2fe9
Inspection Facts
- Inspection number
- 1024531
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lupin Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 15, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| April 26, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Lupin Ltd.
- FDA Inspection 1280668 - 2025-09-05
- FDA Inspection 1235550 - 2024-03-15
- FDA Inspection 1121188 - 2020-02-14
- FDA Inspection 1090546 - 2019-05-15
- FDA Inspection 1012780 - 2017-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.